Point of Care Testing 2: Exciting New Directions

Qualifies for 5.5 Hours of CEUs

Monday, May 11, 2009 
at
The Doubletree Hotel San Diego Downtown
located at
1646 Front Street
San Diego, California

Overview:

The TriMark Point of Care Testing Conference 2009 has been organized to provide a critical examination of the point of care industry, as well as valuable insights from key industry leaders concerning new cutting edge point of care technologies, and the impact on clinical medicine. This conference will also provide a forum for leaders in point of care technology sector, point of care coordinators, laboratory directors and clinical laboratorians to share ideas, network with other delegates and advance understanding of the potential of new point of care technologies for improving medical care delivery. The Conference's keynote speaker is:

James H. Nichols, Ph.D., DABCC, FACB Dr. Nichols is a Professor of Pathology at Tufts University School of Medicine and Director, Clinical Chemistry for Baystate Health in Springfield, MA. Dr. Nichols received his B.A. in General Biology/Pre-medicine from Revelle College, University of California at San Diego. He went on to complete a Masters and Doctorate in Biochemistry from the University of Illinois, Urbana-Champaign. Dr. Nichols was a fellow in the Postdoctoral Training Program in Clinical Chemistry at the Mayo Clinic, Rochester, MN. He is board certified in both Clinical Chemistry and Toxicological Chemistry by the American Board of Clinical Chemistry. Dr. Nichols spent several years as Associate Director of Clinical Chemistry, Director of Point-of-Care Testing, and an Associate Professor of Pathology at Johns Hopkins Medical Institutions prior to moving to Massachusetts. Baystate Health includes Franklin Medical Center, Mary Lane Hospital and Baystate Medical Center, a leading acute care center in New England. Dr. Nichols is responsible for Clinical Chemistry including core automated chemistry, immunoassay, endocrinology, toxicology/therapeutic drug analysis, esoteric and point of care testing conducted through Baystate Reference Laboratories, one of America’s largest hospital-based outreach programs. Dr. Nichols’ research interests span evidence-based medicine, information management, laboratory automation, point-of-care testing and toxicology.

Who Should Attend:

• Point of care coordinators.
• Medical technologists and laboratorians.
• Laboratory directors and supervisors.
• Point of care technology development companies.
• Physicians and clinical scientists.
• Industry representatives and researchers.
• Regulatory personnel.

Leaders from the Following Areas Will Greatly Benefit from Attending:

• Laboratory leaders.
• Hospital CFOs and CSOs.
• Point of care and in vitro diagnostic companies.
• Business development.
• Strategic planning and development.
• Technology development.
• Marketing.
• Research and development.

Key Themes:

• A critical examination of key emerging technologies in point of care testing.
• Transitioning from laboratory in vitro diagnostics to point of care diagnostics.
• Evidence-based medicine in point of care testing.
• Point of care testing as an essential critical care medicine tool.
• Point of care testing is an important resource tool for practicing family medicine.

Issues Addressed at the TriMark Conference:

• How to achieve quality in point of care testing.
• How to implement point of care testing to improve patient outcomes.
• The impact of molecular diagnostics on point of care testing.
• Which new technologies will reach the point of care market in the next 2-3 years?
• Point of care testing in rapid diagnosis of AMI in the ED.
• What are the prospects for point of care testing in the future?
• How is technology innovation facilitating the transition of POC testing into standard healthcare practice?

Top Five Reasons To Attend the TriMark Conference:

• Discover the point of care sectors with the greatest impact on patient care.
• Identify the key players in the point of care market and recognize how their technology platforms can energize point of care testing.
• Understand the factors driving growth of the point of care market, which represents over 30% of global in vitro diagnostics sales.
• Discover the future of point of care testing.
• See the top innovators in point of care testing technology.

Schedule:

• Registration at 8:00 am.
• Lunch at 12:30 pm.
• Networking at 6:00 pm.